Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal

Circulation Research

Volumn 83, Issue 4, 1998, Pages 378-387

  Kockx, Mark M ^a   De Meyer, Guido R Y ^b   Buyssens, Norbert ^b   Knaapen, Michiel W M ^c   Bult, Hidde ^b   Herman, Arnold G ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Applied Cardiovascular Morphology   (Belgium)

Author keywords

Apoptosis; Atherosclerosis; BAX; Smooth muscle cell; Terminal deoxynucleotidyl transferase nick end labeling

Indexed keywords

CHOLESTEROL; DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN BAX;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL COMPOSITION; CELL DIVISION; CHOLESTEROL DIET; CONTROLLED STUDY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0032563650     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.4.378     Document Type: Article

References (49)

1. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation. 1996;94:2013-2020.
2. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 1996;7:330-335.
3. Moreno PR, Falk E, Palacios IF, Newell JB, Foster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Circulation. 1994;90: 775-778.
4. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
5. Kockx MM, De Meyer GRY, Muhring J, Bult H, Bultinck J, Herman AG. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis. 1996;120:115-124.
6. Kockx MM, Cambier BA, Bortier HE, De Meyer GRY, Declercq SC, Van Cauwelaert PA, Bultinck J. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology. 1994;25: 365-371.
7. Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996;149:367-380.
8. Kockx MM, De Meyer GRY, Bortier HE, de Meyere N, Muhring J, Bakker A, Jacob W Van Vaeck L, Herman AG. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation. 1996;94: 1255-1262.
9. Hegyi L, Skepper JN, Cary NR, Mitchinson MJ. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 1996;180:423-442.
10. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin 1β-converting enzyme. Am J Pathol. 1995;147:251-266.
11. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
12. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
13. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin Cell Biol. 1995;7:337-343.
14. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
15. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
16. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CY, van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993;41:7-12.
17. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol. 1993;170:1-8.
18. Kockx MM, Muhring J, Bortier H, De Meyer GRY, Jacob W. Biotin or digoxigenin conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 1996;148:1771-1777.
19. Anitschkow N. Über die Rückbildungsvorgänge bei der experimentellen Atherosklerose. Verh Dtsch Ges Pathol. 1928;43:473-478.
20. Friedman M, Byers SO. Observations concerning the evolution of atherosclerosis in the rabbit after cessation of cholesterol feeding. Am J Pathol. 1963;43:349-359.
21. Armstrong ML. Connective tissue in regression. In: Paoletti R, Gotto AM Jr, eds. Atherosclerosis Reviews. New York, NY: Raven Press Publishers; 1978;3:147-168.
22. Albrecht W, Schuler W. The effect of short-term cholesterol feeding on the development of aortic atheromatosis in the rabbit, I: the influence of hypercholesterolaemia on lipid deposition in the aorta, liver and adrenals. J Atheroscler Res. 1965;5:353-368.
23. Adams CW, Morgan RS, Bayliss OB. No regression of atheroma over one year in rabbits previously fed a cholesterol-enriched diet. Atherosclerosis. 1973;18:429-444.
24. Stary HC. Regression of atherosclerosis in primates. Virchows Arch. 1979;383:117-134.
25. St. Clair RW. Atherosclerosis regression in animal models: current concepts of cellular and biochemical mechanisms. Prog Cardiovasc Dis. 1983;26:109-132.
26. Wissler RW. Current status of regression studies. In: Paoletti R, Gotto AM Jr, eds. Atherosclerosis Reviews. New York, NY: Raven Press Publishers: 1978;3:213-229.
27. Armstrong ML. Regression of atherosclerosis. In: Paoletti R, Gotto AM Jr, eds. Atherosclerosis Reviews. New York, NY: Raven Press Publishers; 1976;1:137-182.
28. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK, Libby P. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998;97: 2433-2444.
29. Daughterly A, Schonfeld G, Sobel BE, Lange LG. Metabolism of very low density lipoproteins after cessation of cholesterol feeding in rabbits. J Clin Invest. 1986;77:1108-1115.
30. Gupta PP, Tandon HD, Ramalingaswami V. Experimental atherosclerosis in rabbits with special reference to reversal. J Pathol. 1970;101:309-317.
31. Bortz WM. Reversibility of atherosclerosis in cholesterol-fed rabbits. Circ Res. 1968;22:135-139.
32. Prior JT, Ziegler DD. Regression of experimental atherosclerosis. Arch Pathol. 1965;80:50-57.
33. Stender S. Turnover of cholesterol in aorta of rabbits previously fed a cholesterol-enriched diet. Atherosclerosis. 1976;23:275-288.
34. Constantinides P, Booth J, Carlson G. Production of advanced cholesterol atherosclerosis in the rabbit. Arch Pathol. 1960;70:712-724.
35. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
36. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
37. Oltvai ZH, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog. BAX, that accelerates programmed cell death. Cell. 1993;74:609-619.
38. Nishio E, Watanahe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and BCL-2 protein downregulation. Biochem Biophys Res Commun. 1996;226:928-934.
39. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of BAX, a dominant inhibitor of Bcl-2. Am J Pathol. 1994;145:1323-1336.
40. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK. Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest. 1984;73: 1590-1605.
41. Stary HC. Arterial cell injury and cell death in hypercholesterolemia and after reduction of high serum cholesterol levels. Prog Biochem Pharmacol. 1977;14:241-247.
42. Rekhter MD, Gordon D. Active cell proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 1995;147:668-677.
43. Sjesjö BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab. 1981;1:155-185.
44. Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH. Inhibition of neointimal cell Bcl-x expression induces apoptosis and regression of vascular disease. Nat Med. 1998;4:222-227.
45. Salvesen GS, Dixit VM. Caspases: intracellular signalling by proteolysis. Cell. 1997;91:443-446.
46. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Involvement of the Fas death-signalling pathway in cytokine-induced apoptosis of vascular smooth muscle cells during atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:2200-2208.
47. Shiomi M, Ito T, Tsukada T, Yata T, Watanabe Y, Tsujita Y, Fukami M, Fukushige J, Hosokawa T, Tamura A. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol. 1995;15:1938-1944.
48. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
49. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347:1447-1449.